Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    16264058 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Escalating and Cumulative-Dose Study of Pharmacokinetics (PK), Pharmacodynamics (PD) and Safety of A006
Conditions: Asthma;   Bronchospasm;   Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Albuterol Inhalation Powder;   Drug: Placebo Control;   Drug: Active Comparator
2 Completed Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Condition: Asthma
Interventions: Drug: A006 DPI;   Other: Placebo DPI;   Drug: Proventil® MDI
3 Completed Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis
Conditions: Cystic Fibrosis;   Pancreatic Insufficiency
Interventions: Drug: PANCRECARB®  (pancrelipase);   Drug: Placebo

Indicates status has not been verified in more than two years